This site is intended for Healthcare Professionals only.

Covid booster: No need for fourth jab at present, says JCVI

Date:

Share post:

A fourth dose of Covid-19 vaccine (covid booster) is not needed at present, as latest data shows first booster provides high levels of protection against Omicron variant among older adults, says the Joint Committee on Vaccination and Immunisation (JCVI).

After analysing latest data from the UK Health Security Agency (UKHSA), JCVI said: “There is no immediate need to introduce a second booster dose, or fourth jab, to the most vulnerable”.

Data from UKSHA revealed that single booster dose provides around 90 per cent protection against hospitalisation to those aged 65 and over, even after three months of jab.

However, protection against mild symptomatic infection is short-lived and drops to around 30 per cent by about three months.

The study, which looked at booster doses in those aged over 65, showed that with two vaccine doses, protection against the infection drops to around 70 per cent after three months and to 50 per cent after six months.

Professor Wei Shen Lim, the JCVI’s chair of Covid-19 immunisation, said: “The current data shows the booster dose is continuing to provide high levels of protection against severe disease, even for the most vulnerable older age groups.

“For this reason, the committee has concluded there is no immediate need to introduce a second booster dose, though this will continue to be reviewed.”

Instead of rolling out a second booster dose, JCVI has advised to prioritise administering first booster dose to all age groups and encouraged unvaccinated individuals to take their first two doses.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

MHRA outlines strategic approach to AI regulation in healthcare for patient safety

MHRA's strategic principles aim to foster innovation while upholding rigorous standards of patient safety and regulatory integrity In a...

CCA report highlights success: 90,000 pharmacy first consultations since launch

The pharmacy first report reveals impressive uptake and patient satisfaction in just two months In a recent report released...

RPS and Pharmacy Support join hands for pharmacy professionals wellbeing

Marks a significant milestone in the pharmacy sector's commitment to nurturing its pharmacy family The Royal Pharmaceutical Society (RPS)...

Atulkumar Patel: A beacon of resilience and innovation in pharmacy practice

Despite offers to join full-time in a GP practice, Patel chose to remain dedicated to his community, becoming...